70 related articles for article (PubMed ID: 11561082)
41. Nociceptin/orphanin FQ modulates cortical activity and trigeminal nociception.
Bongsebandhu-Phubhakdi S; Phisonkulkasem T; Srikiatkhachorn A
Headache; 2011 Sep; 51(8):1245-53. PubMed ID: 21797854
[TBL] [Abstract][Full Text] [Related]
42. Central injections of nocistatin or its C-terminal hexapeptide exert anxiogenic-like effect on behaviour of mice in the plus-maze test.
Gavioli EC; Rae GA; Calo' G; Guerrini R; De Lima TC
Br J Pharmacol; 2002 Jul; 136(5):764-72. PubMed ID: 12086986
[TBL] [Abstract][Full Text] [Related]
43. Strain-dependent effects of supraspinal orphanin FQ/nociceptin on thermal nociceptive sensitivity in mice.
Mogil JS; Nessim LA; Wilson SG
Neurosci Lett; 1999 Feb; 261(3):147-50. PubMed ID: 10081970
[TBL] [Abstract][Full Text] [Related]
44. Effects of intrathecal orphanin FQ on a flexor reflex in the rat after inflammation or peripheral nerve section.
Xu IS; Grass S; Wiesenfeld-Hallin Z; Xu XJ
Eur J Pharmacol; 1999 Apr; 370(1):17-22. PubMed ID: 10323275
[TBL] [Abstract][Full Text] [Related]
45. Dynorphin A inhibits nociceptin-converting enzyme from the rat spinal cord.
Suder P; Wade D; Łegowska A; Kotlińska J; Rolka K; Silberring J
Biochem Biophys Res Commun; 2001 Oct; 287(4):927-31. PubMed ID: 11573954
[TBL] [Abstract][Full Text] [Related]
46. Degradation of nociceptin (orphanin FQ) by mouse spinal cord synaptic membranes is triggered by endopeptidase-24.11: an in vitro and in vivo study.
Sakurada C; Sakurada S; Orito T; Tan-No K; Sakurada T
Biochem Pharmacol; 2002 Oct; 64(8):1293-303. PubMed ID: 12234609
[TBL] [Abstract][Full Text] [Related]
47. Nociceptin/orphanin FQ-induced nociceptive responses through substance P release from peripheral nerve endings in mice.
Inoue M; Kobayashi M; Kozaki S; Zimmer A; Ueda H
Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10949-53. PubMed ID: 9724810
[TBL] [Abstract][Full Text] [Related]
48. Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice.
Binaschi A; Zucchini S; Bregola G; Rodi D; Mazzuferi M; Reinscheid RK; Simonato M
Neuroreport; 2003 May; 14(6):825-7. PubMed ID: 12858040
[TBL] [Abstract][Full Text] [Related]
49. Plasma concentrations of nociceptin/orphanin FQ: comparison of levels after general and neuraxial anesthesia for arthroscopic knee surgery.
Lee H; Jeon H
Korean J Anesthesiol; 2013 Oct; 65(4):327-30. PubMed ID: 24228146
[TBL] [Abstract][Full Text] [Related]
50. Study of the cytotoxicity and antioxidant capacity of N/OFQ(1-13)NH2 and its structural analogues.
Kirkova M; Zamfirova R; Leśkiewicz M; Kubera M; Lasoń W; Todorov S
Pharmacol Rep; 2009; 61(6):1163-72. PubMed ID: 20081252
[TBL] [Abstract][Full Text] [Related]
51. In vivo molecular signal transduction of peripheral mechanisms of pain.
Ueda H
Jpn J Pharmacol; 1999 Mar; 79(3):263-8. PubMed ID: 10230852
[TBL] [Abstract][Full Text] [Related]
52. [Electrical activity of nerves induced by thiamine polyphosphoric amide esters in the spinal-cord sectioned rabbit].
Roux H; Jacquet-Francillon ML; Bouteille H
J Physiol (Paris); 1965; 57(5):693-4. PubMed ID: 5847161
[No Abstract] [Full Text] [Related]
53. Correction to: Electrophysiological Actions of N/OFQ.
Winters BL; Christie MJ; Vaughan CW
Handb Exp Pharmacol; 2019; 254():417. PubMed ID: 31152275
[TBL] [Abstract][Full Text] [Related]
54. The National Oncology PET Registry (NOPR): A monumental effort by a few leaders.
Czernin J
J Nucl Med; 2018 Jan; ():. PubMed ID: 29371409
[No Abstract] [Full Text] [Related]
55. The pharmacology of Ro 64-6198, a systemically active, nonpeptide NOP receptor (opiate receptor-like 1, ORL-1) agonist with diverse preclinical therapeutic activity.
Shoblock JR
CNS Drug Rev; 2007; 13(1):107-36. PubMed ID: 17461893
[TBL] [Abstract][Full Text] [Related]
56. Pronociceptive effects of nociceptin/orphanin FQ (13-17) at peripheral and spinal level in mice.
Inoue M; Matsunaga S; Rashid MH; Yoshida A; Mizuno K; Sakurada T; Takeshima H; Ueda H
J Pharmacol Exp Ther; 2001 Oct; 299(1):213-9. PubMed ID: 11561082
[TBL] [Abstract][Full Text] [Related]
57. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord.
Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H
J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918
[TBL] [Abstract][Full Text] [Related]
58. Nocistatin and prepro-nociceptin/orphanin FQ 160-187 cause nociception through activation of Gi/o in capsaicin-sensitive and of Gs in capsaicin-insensitive nociceptors, respectively.
Inoue M; Kawashima T; Allen RG; Ueda H
J Pharmacol Exp Ther; 2003 Jul; 306(1):141-6. PubMed ID: 12665541
[TBL] [Abstract][Full Text] [Related]
59. Antinociceptive effects of spinally administered nociceptin/orphanin FQ and its N-terminal fragments on capsaicin-induced nociception.
Katsuyama S; Mizoguchi H; Komatsu T; Sakurada C; Tsuzuki M; Sakurada S; Sakurada T
Peptides; 2011 Jul; 32(7):1530-5. PubMed ID: 21672568
[TBL] [Abstract][Full Text] [Related]
60. Involvement of NMDA receptor in nociceptive effects elicited by intrathecal [Tyr6] gamma2-MSH(6-12), and the interaction with nociceptin/orphanin FQ in pain modulation in mice.
Chang M; Li W; Peng YL; Gao YH; Yao J; Han RW; Wang R
Brain Res; 2009 May; 1271():36-48. PubMed ID: 19332041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
